One Pager as on February 29, 2024
Prudent portfolio of investments across companies and sectors. | |
Actively managed by professional fund managers for potential long term capital appreciation. | |
Opportunity to participate in successful businesses through equity market. | |
Sector | MMMCF | Nifty 500 Multicap 50:25:25 TRI Index |
Financial Services | 17.52% | 26.38% |
Information Technology | 11.72% | 9.24% |
Oil Gas & Consumable Fuels | 9.77% | 7.41% |
Capital Goods | 8.98% | 8.01% |
Construction | 7.97% | 3.14% |
Data as on February 29, 2024
Security | % to Net Assets |
Canara Bank | 4.51% |
Coal India Limited | 4.43% |
Tata Consultancy Services Limited | 3.99% |
Hindustan Petroleum Corporation Limited | 3.81% |
NTPC Limited | 2.84% |
Tata Power Company Limited | 2.82% |
Larsen & Toubro Limited | 2.63% |
Tata Motors Limited | 2.50% |
Wipro Limited | 2.10% |
IRCON International Limited | 2.04% |
Total | 31.66% |
Fresh Additions | Complete Exits |
Security | Security |
Dr. Reddy's Laboratories Limited | BEML Limited |
Kalpataru Projects International Limited | Cummins India Limited |
Sun Pharmaceutical Industries Limited | IndusInd Bank Limited |
The South Indian Bank Limited | One 97 Communications Limited |
SJVN Limited |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant
portfolio changes during the month and should not be construed as recommendation to buy/sell/
hold. The fund manager may or may not choose to hold these companies/stocks, from time to
time. Investors are requested to consult their financial, tax and other advisors before taking any
investment decision(s). Data as on February 29, 2024
Turnover Ratio (Last 1 year) | 1.14 |
Standard Deviation | 14.32% |
Beta | 0.97 |
Sharpe Ratio# | 1.20 |
Jenson's Alpha | 0.1915 |
#Risk-free rate assumed to be 6.80% (MIBOR as on 29-02-24) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns
for last 3 years. Data as on February 29, 2024
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different
Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha is managing this fund since December 21, 2020. Ms. Fatema Pacha is managing this scheme since October 16, 2020.
*Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been
considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth
Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha manages 10 schemes and Ms. Fatema Pacha
manages 8 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on February 29, 2024
This product is suitable for investors who are seeking*:
• Medium to Long term capital
appreciation.
• Investment predominantly in
equity and equity related securities
including derivatives.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.